Respected Molecular Pathologist Appointed New Editor-in-Chief of The Journal of Molecular Diagnostics
Philadelphia, PA, October 23, 2014
The editorial direction of The Journal of Molecular Diagnostics (JMD) is transferringto the stewardship of respectedmolecular pathologist Barbara A.Zehnbauer, Ph.D., FACMG, FACB, on January1, 2015.
Dr. Zehnbauer servesthe public at the Centersfor Disease Controland Prevention in Atlanta, GA, where she is Chief of the Laboratory Research and Evaluation Branch in the Divisionof Laboratory Programs, Standards, and Services. She also holds an adjunct facultyappointment in Pathology at Emory University. Dr. Zehnbauer's editorial experience derivesfrom volunteering as an Associate Editor for JMD since 2006, rising to SeniorAssociate Editor in 2009.
The JMD publishes high quality original papers on scientific advances in the translation and validationof molecular discoveries in medicineinto the clinical diagnostic setting. First published in 1999, the Journalis read by the global molecularpathology community and reviews submissionsfrom over 35 countries. JMD also promotes educationand discourse by publishing peer-reviewed guidelines andposition statements from theAssociation for Molecular Pathology (AMP), which co-owns JMD.
Dr. Zehnbauer has been an activemember of AMP since 1996, serving in several capacities, including Genetics Subdivision Chair (2001-2002), President (2006), Chair of the Nominating Committee (2005 and 2007), Chair of theProgram Committee (2010), andCouncilor (2009-2010). Regarding her continued support of AMP through her JMD editorial appointment, Dr. Zehnbauer stated, "It is an honor and a privilegeto have the opportunity to expandJMD support of the AMP missions and the accessibilityto AMP products through innovative content and communication."
Dr. Zehnbauer earned her Ph.D. in Microbiology from the University of Chicago and completedpostdoctoral training at The Johns Hopkins University School of Medicine whereshe continued as faculty in Oncologyand Director of the Recombinant DNA Diagnostic Laboratory. From there she movedto Washington University School of Medicine in St. Louis and was promoted toProfessor of Pathology and Immunology, directing both the clinical Molecular Diagnostic Laboratory and theSiteman Cancer Center Molecular Core Laboratory.
Dr. Zehnbauer's interests lie in strengthening the laboratory workforce through education of laboratory quality services and policy, defining lab practices for certification compliance, and quality improvementin clinical molecular pathologyand genetics. In 2013 she was recognized by the Clinical and Laboratory Standards Institutefor Excellence in Standards Development.
JMD, which is published by Elsevier,Inc., is the official journal of AMP and is co-owned by the American Society for Investigative Pathology(ASIP). Mary Steele Williams, MNA, MT(ASCP)SM, CAE, ExecutiveDirector for AMP, said,"We are very excited to have Dr. Zehnbauer named the nextEditor-in-Chief of JMD. Her strengthsas a scientist and leader in the genetics and pathology communities will serve theJournalwell." ASIP's Executive Officer,Mark E. Sobel, M.D., Ph.D., added that, "Dr. Zehnbauer brings her particular expertise in inherited diseasesand quality control and validation, areas that are of prime importanceas we confront the challenges of genomics in the diagnostic arena."
Timothy J.O'Leary, M.D., Ph.D., Washington, DC, current Editor-in-Chief of JMD, applauded the selection saying, "Dr. Zehnbauer is a carefulscientist whose sound judgment will undoubtedly lead JMD to new heights."
Notes for editors
For more information about Dr. Zehnbauer, please contactDr. John P. Anderton, Associate DirectorforCommunications Science, CDC,1600Clifton Road, NE, MS E-94, Atlanta, GA 30333. Phone:+1 404 498 6145; Email:JAnderton@cdc.gov.
For more information on The Journal of Molecular Diagnostic or the AmericanSociety for Investigative Pathology, pleasecontact Dr. Audra E. Cox, Managing Editor, The Journal of Molecular Diagnostics, 9650 Rockville Pike, Bethesda MD 20814. Phone: +1 301634 7409; Fax: +1 301634 7961; Email: email@example.com.
For more information on the Association for Molecular Pathology, please contact MaurissaMessier, Bioscribe. Phone: +1 7606596700; Email: firstname.lastname@example.org.
About The Journalof Molecular Diagnostics
The Journal of Molecular Diagnostics (http://jmd.amjpathol.org), the official publication of the Association for Molecular Pathology (AMP), co-owned by the American Society for Investigative Pathology (ASIP), seeks to publishhigh qualityoriginal paperson scientific advances in the translation and validation of molecular discoveries in medicine into the clinicaldiagnostic setting, and the description andapplication of technological advances in the field of moleculardiagnostic medicine. The editors welcome review articles that contain:novel discoveries orclinicopathologic correlationsincluding studies in oncology, infectious diseases, inherited diseases,predisposition todisease, or the description orpolymorphismslinked to disease states or normal variations;the application of diagnostic methodologies in clinical trials; or thedevelopment of new or improved molecular methodsfor diagnosis or monitoringof disease ordisease predisposition.
The leading journal for reporting advances in the fieldof molecular diagnostic medicine, The Journalof MolecularDiagnostics ranks 13thamong 76 journals in Pathology, with an ImpactFactor of 3.955, according to 2013 JournalCitationReports® Thomson Reuters,2014.
About The Association for Molecular Pathology
The Association for Molecular Pathology (AMP) was founded in 1995 to provide structure and leadership to the then-emerging field ofmolecular diagnostics. Through its Board ofDirectors and Committees, AMP pursues topics of importance to those at the forefront of their growing discipline. From the beginning, AMP has worked to develop mechanisms for training and certification in diagnostic molecular pathology. AMP hasassumed national visibility with its efforts to shaperegulationsand policy that influence research andthe practice ofmoleculardiagnostics. Theorganization isdivided into the scientific subdivisions of genetics, infectious diseases,hematopathology, and solid tumors. Each subdivision addresses issues, identifiesgoals, shapes policy, andprovides member benefits specificto thatparticular discipline. Members can participate in anyor all of thesesubdivisions. (http://www.amp.org)
About The American Society for Investigative Pathology
The American Society for Investigative Pathology (ASIP) is a society of biomedical scientistswho investigate mechanismsofdisease. Investigative pathology is an integrativediscipline that links the presentation of disease in the whole organismto its fundamental cellular and molecular mechanisms. It uses a variety of structural, functional, and genetic techniques andultimatelyapplies research findings to the diagnosisand treatment of diseases. ASIP advocates for the practice of investigativepathologyandfosters the professional careerdevelopmentand education of its members. (http://www.asip.org)
Elsevier is a global information analytics business that helps scientists and clinicians to find new answers, reshape human knowledge, and tackle the most urgent human crises. For 140 years, we have partnered with the research world to curate and verify scientific knowledge. Today, we’re committed to bringing that rigor to a new generation of platforms. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education; including ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath. Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell, 39,000 e-book titles and many iconic reference works, including Gray's Anatomy. Elsevier is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers. www.elsevier.com
+1 732 238 3628